483
Lex, Inc.Lex, Inc. – FDA 483, Feb 28, 2023
Record Details
Lex Inc. DBA Lex Pharmaceutical in Medley, FL, was cited for significant deficiencies in its manufacturing of OTC drugs and dietary supplements. The inspection revealed widespread issues including inadequate raw material testing, lack of process validation, and poor quality control practices. Many of these observations were repeats from prior FDA inspections, indicating a persistent failure to implement corrective actions.
View Company Profile
ID · 85bece66-fe44-4c99-878d-421e16e8dffb
Other documents for Lex, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.